“…In which, the formation of its salts or co-crystals has attracted the field of crystal engineering because of the change in properties of a drug using a generally regarded as safe [4] coformer, especially to get advantageous solubility, bioavailability, stability and good tablet processing qualities [5][6][7][8]. Almost 40% of the APIs in the market today face a major problem of poor solubility [9].…”